We first selected 10 patients including 8 WM (WM1-WM8), 1 non-IgM-secreting LPL (NHL1), and 1 low grade B-cell lymphoma with IgG M-protein (NHL3) for cloning (Table 2). This evidence concerns the gene LPL and B-cell non-Hodgkin lymphoma.